IGC Pharma, Inc. (IGC)
0.30
+0.01
(+3.16%)
USD |
NYAM |
Dec 09, 14:53
IGC Pharma Total Liabilities (Quarterly): 1.651M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | -- |
| Theravance Biopharma, Inc. | 182.78M |
| NRX Pharmaceuticals, Inc. | 40.75M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.743M |
| Shareholders Equity (Quarterly) | 8.092M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 1.324 |
| Net Debt Paydown Yield | 0.10% |